Meet Valar MBA alum, Emma Bardin, a writer, entrepreneur, and consultant dedicated to making complex science clear, compelling, and actionable. As the Principal at Bardin Consulting, Emma helps life science companies communicate groundbreaking innovations with precision and impact.

Her journey began in the classroom, first as a writing professor, then as a calculus tutor, where she honed her ability to break down intricate concepts for diverse audiences. That skill set proved invaluable as she transitioned into life science content writing, an industry experiencing rapid growth as the demand for clear, science-based communication soars.

With the global life science content writing industry projected to reach $8.4 billion by 2030, the field has become increasingly essential for biotech, pharmaceutical, and healthcare companies. As medical advancements accelerate, particularly in areas like genomics, precision medicine, and AI-driven drug discovery, the need for expert science communicators has never been greater. Companies must bridge the gap between technical research and key stakeholders, whether it’s investors, regulators, healthcare providers, or the general public. The demand for specialized content, from regulatory documents and medical writing to investor reports and thought leadership pieces, is fueling this industry’s expansion, positioning skilled science writers as invaluable partners in innovation.

Through Bardin Consulting, Emma collaborates with biotech and pharmaceutical companies across the U.S. and Europe, crafting everything from case studies and thought leadership articles to investor slide decks and press releases. Her ability to strike the perfect balance between scientific accuracy and accessibility has made her a sought-after expert in the field, with her work featured in Forbes, Bio-IT World, and Medical Economics. 

While her writing expertise was well established, Emma knew that to scale her business, she needed to refine her approach to strategy, operations, and leadership. Pursuing her Valar Executive MBA gave her the tools to formalize business processes, strengthen investor messaging, and mentor emerging startups. The impact was immediate, the same year she graduated, Bardin Consulting hit six figures, proving the power of combining science, communication, and business acumen.

For Emma, great leadership is about clarity, aligning stakeholders, simplifying complexity, and leveraging strengths to drive impact. As she continues expanding her work across genomics, metabolomics, and beyond, her mission remains the same: to bridge the gap between cutting-edge science and the people who need to understand it.